Cytek Biosciences, Inc.

Thank you for standing by. At this time, I would like to welcome everyone to the SciTech Biosciences first quarter 2025 earnings conference call. All lines have been placed on mute to prevent any background noise. After the speaker's remarks, there will be a question and answer session. If you would like to ask a question during this time, simply press star followed by the number one on your telephone keypad. If you would like to withdraw your question, press star one again. I would now like to turn the conference over to Paul Goodson, Head of Investor Relations. Please go ahead, sir.

Thank you, Operator. Earlier today, SciTech Biosciences released financial results for the first quarter ended March 31, 2025. If you haven't received this news release or if you'd like to be added to the company's distribution list, please send an email to investors at scitechbio.com. A copy of the news release is also available on the investor relations section of Scitech's website at investors.scitechbio.com. Joining me today from Scitech are Wenbin Zhang, CEO, and Bill McComb, CFO. Please note that we will be referencing a slide presentation during the call today that has been posted to the investor section of our corporate website. As a reminder, we will make statements during the call that are forward-looking statements within the meaning of the federal securities laws, including statements regarding SITAC's business plans, strategies, opportunities, and financial projections. These statements are based on the company's current expectations and inherently involve significant risks and uncertainties that could cause actual results or events to materially differ from those anticipated in these statements. Additional information regarding these risks and uncertainties appears in our slide presentation in the section entitled Forward Looking Statements in the press release CITEC issued today and in CITEC's filings with the SEC. This call will also include a discussion of certain financial measures that are not calculated in accordance with generally accepted accounting principles. Additional information regarding our use of non-GAAP financial measures, including reconciliations for the most directly comparable GAAP financial measures, may be found in our slide presentation and in today's press release. While the company believes these non-GAAP financial measures provide useful information for investors, the presentation of this information is not intended to be considered in isolation or as a substitute for the financial information presented in accordance with GAAP. Except as required by law, SciTech disclaims any duty to update any forward-looking statements, whether because of new information, future events, or changes in its expectations. This conference call contains substantive information and is accurate only as of the live broadcast May 8, 2025. Finally, I would like to invite analysts and institutional investors to attend any of the six user group meetings SciTech will be hosting in 2025. These are typically all-day meetings where SciTech scientists and users of SciTech's instruments meet to discuss research initiatives, advances in the field, and use cases for SciTech's products. The next meeting will be in La Jolla on May 15th at the Estancia Hotel. In addition to SciTech's user group meetings this year, there will be a variety of industry and academic conferences, meetings, and seminars where we will be exhibiting Scitex products in the U.S. and around the world. While these events are primarily geared to the scientific community, they may offer an opportunity to interact with users of our technologies to learn why Scitex instruments are so highly valued by our customers. We have a limited number of spaces to accommodate members of the financial community, so if you are interested in attending any of these events, please contact me. With that, I would like to turn the call over to Wenbin.

Thanks, Paul. Welcome, everyone, and thank you for your interest in SciTech.